Picture [iito] No Content Marketing 650x80px

News > All

Total search results: 6736 | Ordered by Date (descending)
1 2 3 ... 66 67 68  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Medicines Discovery Catapult (MDC). (8/11/22). "Press Release: Medicines Discovery Catapult and Zeiss Set Sights on Advancing Microscopy. Driving the Application of Microscopy in Drug Discovery". 2022-08-11
Evitria AG. (8/8/22). "Press Release: Genovis AB Enters Service Agreement with Evitria AG for Fast LC-MS Analysis of Recombinant Antibodies". 2022-08-08
Sartorius AG. (8/8/22). "Press Release: Sartorius to Acquire Albumedix, Strengthening Its Portfolio of Innovative Advanced Therapy Solutions". Göttingen. 2022-08-08
BioNTech SE. (8/5/22). "Press Release: BioNTech and Genmab Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy Candidates". Mainz & Copenhagen. 2022-08-05
Poseida Therapeutics, Inc.. (8/3/22). "Press Release: Poseida Therapeutics Announces Strategic Global Collaboration with Roche Focused on Allogeneic CAR-T Cell Therapies for Hematologic Malignancies". San Diego, CA. 2022-08-03
Quantro Therapeutics GmbH. (8/3/22). "Press Release: Quantro Therapeutics Collaborates with Boehringer Ingelheim to Develop Drug Candidates Interfering with Transcriptional Regulators". Vienna. 2022-08-03
Formycon AG. (8/3/22). "Press Release: U.S. Food and Drug Administration (FDA) Approved FYB201/Cimerli (ranibizumab-eqrn), the First and Only Biosimilar Interchangeable with Lucentis". Munich, Amsterdam & Zug. 2022-08-03
ResMed Inc.. (8/2/22). "Press Release: ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio". Martinsried & Leipzig. 2022-08-02
NLC Ventures Netherlands B.V.. (8/2/22). "Press Release: Haermonics Series A Funding Offers Pure™ Promise for Future Heart Surgery Patients". Eindhoven. 2022-08-02
Eppendorf SE. (8/1/22). "Press Release: Eppendorf Opens New Site in Singapore". Singapore & Hamburg. 2022-08-01
Scienion GmbH. (7/28/22). "Press Release: Scienion Announces Expansion in the UK with the Opening of New R&D and Manufacturing Facilities". Lakeside North Harbour, Portsmouth. 2022-07-28
Cleerly, Inc.. (7/28/22). "Press Release: Heart Health Innovator Cleerly Closes Series C Funding Round with $223 Million [updated version of press release from 25 July]". New York, NY. 2022-07-28
Ginkgo Bioworks Inc.. (7/25/22). "Press Release: Ginkgo and Bayer Sign Definitive Agreement to Build Agricultural Biologicals R&D Platform Capabilities". Boston, MA. 2022-07-25
NeoSphere Biotechnologies GmbH. (7/25/22). "Press Release: NeoSphere Biotechnologies Closes Financing Round to Expand Proteomics Platform for Systematic Identification of Novel Targets for Targeted Protein Degradation". Munich. 2022-07-25
Sartorius AG. (7/21/22). "Press Release: Sartorius Remains on Growth Track. Figures for the First Half of 2022 – Sales Revenue up 20.9 Percent in Constant Currencies, Underlying EBITDA up 25.6 Percent, Underlying EBITDA Margin 33.9 Percent". Göttingen. 2022-07-21
Sartorius Stedim Biotech S.A.. (7/21/22). "Press Release: Half-year Results 2022 of Sartorius Stedim Biotech. Sales Revenue up 22.1 Percent in Constant Currencies, Underlying EBITDA Margin 35.2 Percent ". Aubagne. 2022-07-21
Forty51 Ventures. (7/18/22). "Press Release: Forty51 Ventures Announces the First Close of Fund I and its First Investment". Luxembourg & Basel. 2022-07-18
Enterome S.A.. (7/18/22). "Press Release: Enterome Signs Major Strategic R&D Collaboration with Nestlé Health Science to Develop and Commercialize New AllerMimics and EndoMimics Immunotherapies for Food Allergies and Inflammatory Bowel Disease". Paris. 2022-07-18
Delfi Diagnostics, Inc.. (7/18/22). "Press Release: Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio of Liquid Biopsy Tests". Baltimore, MD & Palo Alto, CA. 2022-07-18
SHS Gesellschaft für Beteiligungsmanagement mbH. (7/18/22). "Press Release: More than 220 Million Euros for Growth and Succession Investments in European Healthcare Companies". 2022-07-18
IZB Martinsried. (7/14/22). "Press Release: Cutting-edge Research at Munich’s IZB Attracts Strong Interest". Martinsried. 2022-07-14
Rubius Therapeutics, Inc.. (7/14/22). "Press Release: Rubius Therapeutics Appoints Susanne Schaffert, Ph.D., to its Board of Directors". Cambridge, MA. 2022-07-14
Heidelberg Pharma AG. (7/13/22). "Press Release: Heidelberg Pharma and Chiome Bioscience Sign Exclusive, Target-Specific Research and Option Agreement for the Development of an Antibody Drug Conjugate (ad hoc)". Ladenburg. 2022-07-13
Mosanna Therapeutics AG. (7/13/22). "Press Release: Mosanna Therapeutics Announces a Seed Financing Round to Advance Development of MOS-118 to Treat Metabolic Obstructive Sleep Apnea". Basel. 2022-07-13
BeiGene, Ltd.. (7/13/22). "Press Release: BeiGene Appoints Chan Lee as General Counsel". Cambridge, MA, Basel & Beijing. 2022-07-13
Corat Therapeutics GmbH. (7/13/22). "Press Release: € 38.7 Mio. German Government Funding for the Clinical Development of a Corona Medication". Braunschweig. 2022-07-13
Adrenomed AG. (7/12/22). "Press Release: Adrenomed Appoints David Germonpré as Chief Financial Officer". Zurich. 2022-07-12
Biosaxony. (7/12/22). "Pressemitteilung: Medical Forge Leipzig lässt die Funken fliegen". 2022-07-12
Delfi Diagnostics, Inc.. (7/12/22). "Press Release: Jessica Meng Joins Delfi Diagnostics as Chief Commercial Officer". Baltimore, MD. 2022-07-12
Anjarium Biosciences AG. (7/12/22). "Press Release: Anjarium Biosciences Appoints Experienced Industry Executives Samantha Vieira as Chief Operating Officer and Nate Massari as Chief Business Officer". Zurich. 2022-07-12
Solvias AG. (7/12/22). "Press Release: Solvias Acquires Cergentis to Bolster Biologics and Cell & Gene Therapy Capabilities". 2022-07-12
Vaccentis AG. (7/12/22). "Press Release: Vaccentis Appoints Martin Munte as CEO and Strengthens Board". Zurich. 2022-07-12
Glycomine, Inc.. (7/11/22). "Press Release: Glycomine Appoints Steven Axon as CEO and Adds Two New Board Directors". San Carlos, CA. 2022-07-11
ADC Therapeutics S.A.. (7/8/22). "Press Release: ADC Therapeutics Announces Exclusive License Agreement with Sobi to Develop and Commercialize Zynlonta (loncastuximab tesirine-lpyl) in Europe and Select International Territories". Lausanne. 2022-07-08
ECBF Management GmbH. (7/7/22). "Press Release: ECBF Expands Its Industrial Biotech Portfolio to Offer Naturally Produced Vitamins". Luxembourg. 2022-07-07
Immunic, Inc.. (7/6/22). "Press Release: Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Maria Törnsén". New York, NY. 2022-07-06
BeiGene, Ltd.. (7/6/22). "Press Release: BeiGene Announces Strategic Research Collaboration with InnoRNA to Jointly Discover Novel mRNA Therapies". Cambride, MA, Basel & Beijing. 2022-07-06
Evotec SE. (7/6/22). "Press Release: Evotec, Boehringer Ingelheim, and bioMérieux Launch Aurobac, a Joint Venture to Fight Antimicrobial Resistance". Germany & France. 2022-07-06
Urovant Sciences. (7/5/22). "Press Release: Urovant Sciences and Pierre Fabre Médicament Enter into Exclusive License Agreement to Commercialize Vibegron for the Treatment of Overactive Bladder in the European Economic Area, UK, and Switzerland". Basel & 2022-07-05
CureVac N.V.. (7/5/22). "Press Release: CureVac Files Patent Infringement Lawsuit in Germany against BioNTech". Tübingen & Boston, MA. 2022-07-05
Evotec SE. (7/5/22). "Press Release: Evotec Completes Acquisition of Rigenerand". Hamburg. 2022-07-05
Scienion GmbH. (7/5/22). "Press Release: Highfield Diagnostics and Scienion Sign Memorandum of Understanding". Southampton & Berlin. 2022-07-05
Wacker Chemie AG. (7/5/22). "Press Release: Wacker to Start Construction of Competence Center for mRNA Actives at Halle Site". Tübingen & Boston, MA. 2022-07-05
Evotec SE. (7/4/22). "Press Release: Evotec SE – Translational BRIDGE Partnership beLAB2122 Selects Oncology Project from Goethe University Frankfurt". Hamburg. 2022-07-04
ADC Therapeutics S.A.. (7/1/22). "Press Release: ADC Therapeutics Appoints Jean-Pierre Bizzari, MD, to Board of Directors". Lausanne. 2022-07-01
Symrise AG. (6/30/22). "Press Release: Symrise Cosmetic Ingredients Enters Strategic Partnership with Evoxx Technologies". Holzminden. 2022-06-30
ADC Therapeutics S.A.. (6/29/22). "Press Release: ADC Therapeutics Doses First Patient in Phase 1b Clinical Trial of Zynlonta (loncastuximab tesirine-lpyl) in Combination with Other Anti-cancer Agents". Lausanne. 2022-06-29
BIO Deutschland e. V.. (6/29/22). "Press Release: President of German Biotechnology Industry Association Elected Chairman of International Umbrella Organization". Berlin. 2022-06-29
ReCode Therapeutics. (6/29/22). "Press Release: ReCode Therapeutics to Expand Next-Generation Delivery Platform and Diversify Genetic Medicines Pipeline with Oversubscribed Series B Financing Totaling $200M". Menlo Park, CA & Dallas, TX. 2022-06-29
Molzym GmbH & Co. KG. (6/29/22). "Press Release: Molzym Announces Double-Digit Million EUR Capital Increase". Bremen. 2022-06-29
mk2 Biotechnologies GmbH. (6/28/22). "Press Release: mk2 Biotechnologies and Sartorius Stedim Biotech Join Forces to Develop a Biologics Production Platform". 2022-06-28
VI Partners. (6/27/22). "Press Release: VI Partners Welcomes Simon Meier as Partner, Healthcare". 2022-06-27
Wacker Chemie AG. (6/2/22). "Press Release: Wacker to Invest Double-Digit Million-Euro Sum in Biotechnology Center". Munich. 2022-06-27
Verve Capital Partners AG (Verve Ventures). (6/24/22). "Press Release: Verve Ventures Launches Investment Fund to Support Portfolio Companies". 2022-06-24
Valneva S.E.. (6/24/22). "Press Release: Valneva Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001". Saint-Herblain. 2022-06-24
Merck KGaA. (6/23/22). "Press Release: Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies". Darmstadt. 2022-06-23
F-Star Therapeutics, Inc.. (6/23/22). "Press Release: invoX Pharma to Acquire F-star Therapeutics, Inc. a Pioneering Next Generation Bispecific Discovery Platform and Clinical Programs". London. 2022-06-23
Valneva S.E.. (6/23/22). "Press Release: Valneva and Pfizer Announce Closing of Equity Investment". Saint-Herblain & New York, NY. 2022-06-23
Ningaloo Biosystems GmbH. (6/22/22). "Press Release: Ningaloo’s Opto-Bioproduction Platform Gets Boost from Investors". Cologne. 2022-06-22
Tolremo Therapeutics AG. (6/22/22). "Press Release: Tolremo Therapeutics AG Announces Appointment of Dr. Karl Schumacher as Chief Medical Officer". Muttenz. 2022-06-22
Precision BioSciences Inc.. (6/21/22). "Press Release: Precision BioSciences Announces In Vivo Gene Editing Collaboration with Novartis to Develop Potentially Curative Treatment for Disorders Including Sickle Cell Disease". Durham, NC. 2022-06-21
Ascenion GmbH. (6/21/22). "Press Release: Carma Fund I Completes First Closing of EUR 47 Million to Accelerate the Transfer of Life-Science Research into Practice". Munich & Frankfurt a. M.. 2022-06-21
Knauer Wissenschaftliche Geräte GmbH. (6/21/22). "Press Release: Knauer Wissenschaftliche Geräte Is Partnering with ModuVision". 2022-06-21
Valneva S.E.. (6/20/22). "Press Release: Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15". Saint-Herblain & New York, NY. 2022-06-20
Kranus Health GmbH. (6/20/22). "Press Release: Kranus Health Closes Series A Financing and Has Now Raised a Total of 8 Million USD for Digital Men's Health". Berlin & München. 2022-06-20
Hong Kong Science and Technology Parks (HKSTP). (6/17/22). "Press Release: HKSTP and Boehringer Ingelheim Venture Fund Launch Co-Incubation Programme to Fast-track R&D in Infectious Diseases and Immunology". Hong Kong. 2022-06-17
Atai Life Sciences N.V.. (6/17/22). "Press Release: Stephen Bardin to Join Atai Life Sciences as CFO Designate". New York, NY & Berlin. 2022-06-17
Ymmunobio AG. (6/16/22). "Press Release: Ymmunobio Signs Collaboration Agreement with Yumab". Riehen. 2022-06-16
Gimv. (6/15/22). "Press Release: Gimv Strengthens Its Position in Life Sciences Venture Capital with the Creation of a New Dedicated Platform". Antwerp. 2022-06-15
HH2E AG. (6/15/22). "Press Release: HH2E and MET Group Establish a Joint Project Company to Develop One of Europe’s Largest Green Hydrogen Production Plants in Lubmin, Germany". 2022-06-15
MorphoSys AG. (6/14/22). "Press Release: MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210". Planegg & South San Francisco, CA. 2022-06-14
Anjarium Biosciences AG. (6/14/22). "Press Release: Anjarium Biosciences Appoints Stephen Yoo, MD as Chief Executive Officer". Schlieren. 2022-06-14
Evotec SE. (6/14/22). "Press Release: Evotec Enters a Drug Discovery Collaboration with Janssen". Hamburg. 2022-06-14
ADC Therapeutics S.A.. (6/13/22). "Press Release: ADC Therapeutics Names David Gilman as Chief Business & Strategy Officer". Lausanne. 2022-06-13
ImCheck Therapeutics S.A.S.. (6/13/22). "Press Release: ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Financing to Advance Clinical Program of First-in-human Gamma-delta T Cell Activating Antibody and Accelerate Development of Disruptive Immuno 2022-06-13
Bayer AG. (6/9/22). "Press Release: Bayer’s Vividion Emerging as Significant Player in San Diego Biotech Hub". Leverkusen & San Diego, CA. 2022-06-09
Pepperprint GmbH. (6/9/22). "Press Release: Pepperprint GmbH Introduces Novel Biomarker Set for Rheumatoid Arthritis Diagnosis at the 13th International Congress on Autoimmunity". Heidelberg. 2022-06-09
BIO Deutschland e. V.. (6/9/22). "Press Release: Biotechnology Sector Posts Record Turnover and R&D Investments". Berlin. 2022-06-09
Relation Therapeutics Ltd.. (6/9/22). "Press Release: Relation Therapeutics, the Active-Graph Machine Learning Drug Discovery Company, Names David Roblin as CEO and Lindsay Edwards as CTO". London. 2022-06-09
Forbion Capital Partners. (6/9/22). "Press Release: Forbion Announces First Close of Forbion Growth Opportunities Fund II at €470 Million". Naarden & Munich. 2022-06-09
Peptone Ltd.. (9/9/22). "Press Release: Peptone Closes a $40M Series-A Funding Round Led by F-Prime and Bessemer Venture Partners". London. 2022-06-09
BioVersys AG. (6/8/22). "Press Release: BioVersys AG Announces Successful First Closing of CHF 24.2 Million Series C Financing to Develop Clinical Pipeline of Novel AMR Therapies". Basel. 2022-06-08
Ariceum Therapeutics GmbH. (6/8/22). "Press Release: Ariceum Therapeutics Launches with EUR 25M Series A to Advance Lead Asset, Satoreotide, for the Treatment of Low- and High-Grade Neuroendocrine Cancers". Berlin. 2022-06-08
Bayer AG. (6/8/22). "Press Release: Bayer’s BlueRock Therapeutics Establishes European Site for Cell Therapy Innovation". Berlin. 2022-06-08
CureVac N.V.. (6/8/22). "Press Release: CureVac Accelerates Oncology Strategy with Acquisition of Frame Cancer Therapeutics, Adding Novel Antigen Discovery Platform". Tübingen & Amsterdam. 2022-06-08
ImmunOs Therapeutics AG. (6/7/22). "Press Release: ImmunOs Therapeutics Raises $74 Million Series B Financing Round". Schlieren & Gaithersburg, MD. 2022-06-07
High-Tech Gründerfonds Management GmbH. (6/7/22). "Press Release: Invasight Closes CHF 4.5 Million Oversubscribed Seed Round". Zurich. 2022-06-07
mk2 Biotechnologies GmbH. (6/7/22). "Press Release: mk2 Biotechnologies, Wacker and TUM Jointly Develop a Process for the Large-scale Production of Antimicrobial Peptides Based on Sustainable Fermentation". 2022-06-07
Upstream Bio (US). (6/2/22). "Press Release: Upstream Bio Launches with $200M Series A Financing to Advance Novel Therapeutics for Allergic and Inflammatory Diseases". Waltham, MA. 2022-06-02
Immatics N.V.. (6/2/22). "Press Release: Immatics and Bristol Myers Squibb Expand Strategic Alliance to Develop Gamma Delta Allogeneic Cell Therapy Programs". Tübingen, Houston, TX & New York, NY. 2022-06-02
Evonik Industries AG. (6/2/22). "Press Release: Evonik Invests US$220 Million in Partnership with the U.S. Government to Build New Lipid Production Facility for mRNA-based therapies in the U.S.". Essen & Parsipanny, NJ. 2022-06-02
Proxygen GmbH. (6/2/22). "Press Release: Proxygen Announces Strategic Collaboration with Merck to Develop Molecular Glue Degraders". Vienna. 2022-06-02
Immunic, Inc.. (6/2/22). "Press Release: Immunic, Inc. Reports Top-Line Data from Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Patients with Moderate-to-Severe Ulcerative Colitis and Provides Corporate Update". New York, NY. 2022-06-02
DSM N.V.. (6/2/22). "Press Release: DSM and Firmenich to Merge, Becoming the Leading Creation and Innovation Partner in Nutrition, Beauty and Well-being [NOT FOR RELEASE WHERE VIOLATION OF LAW]". Vienna. 2022-06-02
BioInnovation Institute (BII). (6/2/22). "Press Release: High-quality Project from EMBL Is the First to Enter the Bio Studio Program". 2022-06-02
Scienion GmbH. (6/1/22). "Press Release: Scienion Appoints Frauke Hein as CEO". Berlin. 2022-06-01
Bayer AG. (5/31/22). "Press Release: BlueRock Therapeutics Announces Completion of Enrollment of Phase 1 Trial in Patients with Parkinson’s Disease". Cambridge, MA. 2022-05-31
BRAIN Biotech AG. (5/30/22). "Press Release: Prof. Dr. Bernhard Hauer Leaves Supervisory Board of BRAIN Biotech AG for personal reasons". Zwingenberg. 2022-05-30
BRAIN Biotech AG. (5/30/22). "Press Release: Ongoing Dynamic Sales Development and Rising Profitability, 6M Reporting". Zwingenberg. 2022-05-30
Evotec SE. (5/30/22). "Press Release: Evotec Adds Cell Therapy Manufacturing Facility with Acquisition of Rigenerand". Hamburg. 2022-05-30
1 2 3 ... 66 67 68  next pagenext page


Picture [iito] Fighting Customers 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [iito] [LSE] Business Portal 650x300px

» top